Autoimmune hepatitis and multiple sclerosis: a coincidental association?

Abstract

In the present study we report, as part of a large multiple sclerosis (MS) cohort (1800 patients), three cases of untreated patients who developed autoimmune hepatitis (AIH). The prevalence of AIH in the general population is about 0.0169% and seems to be higher in our MS cohort (0.17%). We suggest that a liver biopsy should systematically be performed in untreated MS patients with a sustained increase of liver enzyme.

Keywords

autoimmune hepatitis biopsy HLA interferor enzyme multiple sclerosis

Get full access to this article

View all access options for this article.

References

Kreisler A , de Seze J , Stojkovic T , Delisse B , Combelles M , Verier A et al. Multiple sclerosis, interferon beta and clinical thyroid dysfunction . Acta Neurol Scand 2003; 107: 154-157 .

Isbister CM , Mackenzie PJ , Anderson D , Wade NK , Oger J. Cooccurrence of multiple sclerosis and myasthenia gravis in British Columbia . Mult Scler 2003; 9: 550-553 .

Attout H , Toussirot E , Auge B , Chavot D , Wendling D. Rheumatoid arthritis and multiple sclerosis in the same patient. Two case-reports . Rev Rheum Engl Ed 1999; 66: 169-172 .

Duchini A. Autoimmune hepatitis and interferon beta 1-a for multiple sclerosis . Am J Gastroenterol 2002; 97: 767-768 .

Corrieri-Baizeau C , Borel I , Cottin V , Vukusic S , Scoazec JY , Audigier JC et al. Autoimmune hepatitis associated with multiple sclerosis . Gastroenterol Clin Biol 2004; 28: 1186-1187 .

Nunez O , de Andres C , Alvarez E , Garcia-Monzon C , Clemente G. Gastroenterol Hepatol 2004; 27: 521-524 .

Alvarez F , Berg PA , Bianchi FB , Bianchi L , Burroughs AK , Cancado EL et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis . J Hepatol 1999; 31: 929-938 .

Danze PM , Bianchi F , Fajardy I , Rousseaux J. An improved strategy for HLA-DRB1 subtyping by digestion of PCR-amplified DNA with allele-specific restriction endonucleases . Appl Theor Electrophor 1995; 5: 7-13 .

Marsh SG. Nomenclature for factors of the HLA system, update January 1995 . Tissue Antigens 1995; 45: 220-222 .

10.

Kurtzke J. Rating neurologic impairment in multiple sclerosis . Neurology 1983; 33: 1444-1452 .

11.

Cooper GS , Stroehla BC. The epidemiology of autoimmune diseases . Autoimmun Rev 2003; 2: 119-125 .

12.

Lucchinetti C , Bruck W , Parisi J , Scheithauer B , Rodriguez M , Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination . Ann Neurol 2000; 47: 707-717 .

13.

Czaja AJ , Shums Z , Norman GL. Nonstandard antibodies as prognostic markers in autoimmune hepatitis . Autoimmunity 2004; 37: 195-201 .

14.

Dyment DA , Ebers GC , Sadovnick AD. Genetics of multiple sclerosis . Lancet Neurol 2004; 3: 104-110 .

15.

Czaja AJ , Freese DK. Diagnosis and treatment of auto-immune hepatitis . Hepatology 2002; 36: 479-497 .

16.

Tremlett H , Oger J. Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis . J Neurol 2004; 251: 1297-1303 .